Identification of ATP synthase beta subunit (ATPB) on the cell surface as a non-small cell lung cancer (NSCLC)

Ze-jun Lu1, Qi-fang Song, Sa-sa Jiang

  • 1Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, 37 Guoxue Xiang Street, Chengdu 610041, Sichuan, PR China. luzejun.01@163.com

BMC Cancer
|January 16, 2009
PubMed
Abstract

Insights

Researchers identified ATP synthase beta subunit (ATPB) as a novel lung cancer biomarker. This ectopically expressed protein on tumor cell membranes shows promise for non-small cell lung cancer (NSCLC) diagnosis and immunotherapy.

Area of Science:

  • Oncology
  • Immunotherapy
  • Biomarker Discovery

Background:

  • Antibody-based cancer immunotherapy shows promise but is limited by the scarcity of known tumor antigens.
  • Identifying novel, immunogenic antigens, particularly cell membrane markers, is crucial for advancing cancer diagnosis and therapy.

Purpose of the Study:

  • To identify novel tumor-associated antigens for non-small cell lung cancer (NSCLC) immunotherapy.
  • To develop a monoclonal antibody targeting a specific lung cancer antigen.
  • To evaluate the potential of the identified antigen as a diagnostic biomarker and therapeutic target.

Main Methods:

  • Immunization of mice with lung adenocarcinoma cell membrane proteins to generate monoclonal antibody 4E7 (McAb4E7).
  • Utilized hybridoma technique, MTT assay, flow cytometry, immunohistochemistry, Western blot, and proteomic technologies (2-DE, mass spectrometry) for antigen identification and validation.
  • Assessed McAb4E7's inhibitory effect on A549 cell proliferation.

Main Results:

  • Successfully produced McAb4E7 with inhibitory effects on A549 cell proliferation.
  • Identified ATP synthase beta subunit (ATPB) as the target antigen for McAb4E7 using proteomic analysis.
  • Confirmed ATPB's surface localization on A549 cells via flow cytometry.
  • Immunohistochemistry revealed aberrant ATPB expression in tumor cell membranes of NSCLC (adenocarcinoma and squamous carcinoma) but not in small cell lung cancer (SCLC), with high ectopic expression rates (71.88% and 66.67% respectively).

Conclusions:

  • Ectopic ATPB in the tumor cell membrane is identified as a non-small cell lung cancer (NSCLC)-associated antigen.
  • ATPB demonstrates potential as a biomarker for NSCLC diagnosis and a therapeutic target for NSCLC immunotherapy.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
The ADP/ATP Carrier Protein01:42

The ADP/ATP Carrier Protein

ADP/ATP carrier or AAC protein is the most abundant carrier protein in the inner mitochondrial membrane. It transports large quantities of ADP and ATP, equivalent to the average human body weight, every day. Among other transporters, ACC protein is one of the best-studied members of the mitochondrial carrier protein family. The ADP/ATP carrier protein comprises two transmembrane helices connected to a loop and a single alpha-helix on the matrix side. It switches between two conformational...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...